Effect of compound Xueshuantong capsule in treatment patients of cataract with proliferative diabetic retinopathy
10.3969/j.issn.1005-1678.2016.12.034
- VernacularTitle:复方血栓通胶囊治疗白内障合并增殖期糖尿病视网膜病变患者的效果观察
- Author:
Xiaojing FAN
;
Guofang ZHANG
- Keywords:
Proliferative diabetic retinopathy;
compound xueshuang capsule;
cataract
- From:
Chinese Journal of Biochemical Pharmaceutics
2016;36(12):121-123
- CountryChina
- Language:Chinese
-
Abstract:
Objective To discuss effect of compound Xueshuantong capsule in in treatment patients of cataract with proliferative diabetic retinopathy.Methods 60 cases of cataract patients with proliferative diabetic retinopathy from February 2015 to February 2016 in our hospital were selected,according to random number table method divided into observation group (n=30) and control group (n=30).The patients in both groups were given basic medical treatment of diabetes,the patients in observation group were treated with Xueshuantong capsule before cataract surgery,continue treatment for three months.The total effective rate of treatment was compared between the two groups,the results of fundus fluorescein angiography and macular thickness before and after treatment were compared,comparison the levels of VEGF in the aqueous humor of the two groups after the treatment. Results The total effective rate of treatment in observation group was significantly higher than control group (P<0.05).After treatment, the number of hemangiomas in the observation group was significantly less than that in the control group (P<0.05),the area of exudation was significantly smaller than that of the control group (P<0.05),the macular thickness of the observation group was significantly lower than the control group (P<0.05),the VEGF content in aqueous humor was significantly lower than that in control group (P<0.05).Conclusion Compound Xueshuantong capsule can significantly improve the retinopathy of cataract patients with proliferative diabetic retinopathy,has a significant effect on decreasing VEGF concentration in aqueous humor and reducing macular edema .
